Clinical trial
A Multicenter, RandoMized, Double-blind, Parallel-grOup, Afluxin® Stick Pack vs. Inactive contRol Clinical Investigation to Evaluate the Performance and Safety in Patients With Gastroesophageal Reflux Disease (GERD)
NCT06984484 is registered in ClinicalTrials.gov with Devintec Sagl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, RandoMized, Double-blind, Parallel-grOup, Afluxin® Stick Pack vs. Inactive contRol Clinical Investigation to Evaluate the Performance and Safety in Patients With Gastroesophageal Reflux Disease (GERD)
- Lead sponsor
- Devintec Sagl
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 2, 2025
- Completion date
- January 31, 2027
- Enrollment
- 208 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
gastroesophageal reflux disease (gerd)